General Surgeons in Rural Areas Need Broad Skill Set for Delivery of Surgical Services
March 5th 2021Data focusing on patients seeking breast surgical procedures determined that broad skill sets are valuable for general surgeons practicing in rural areas, as breast surgeries only represented a small proportion of total surgical procedures conducted.
Neratinib Combo Improves Outcomes in Patients With HER2+ Metastatic Breast Cancer With CNS Disease
March 5th 2021The addition of neratinib to capecitabine improved progression-free survival and central nervous system outcomes in patients with HER2-positive metastatic breast cancer with central nervous system disease.
Patricia Jakel, RN, MN, AOCN, On Treating Patients with CDK 4/6 Inhibitors
March 15th 2020The clinical nurse specialist was also diagnosed with stage III invasive lobular breast cancer and was treated with CDK 4/6 inhibitors, giving her the unique opportunity to speak to both the patient and clinical perspective.
Study Design for the Phase III GLORIA Trial of OBI-822/OBI-821 Vaccine Combination
March 7th 2020The goal of the study is to determine the effect of adagloxad simolenin administered with the potent adjuvant OBI-821 as a therapeutic vaccine treatment on improving invasive disease-free survival in the study population.
Antibody Drug Conjugates in Metastatic Breast Cancer
March 6th 2020Aditya Bardia, MD, MPH detailed the clinical development of antibody drug conjugates in patients with metastatic triple negative breast cancer, as well as what to expect moving forward with antibody drug conjugates in the metastatic breast cancer space.